- Abstract:
-
Cellular senescence is an irreversible side effect of some pharmaceuticals which can contribute to tissue degeneration.To determine whether pharmaceutical glucocorticoids induce senescence in tenocytes.Features of senescence (β-galactosidase activity at pH 6 (SA-β-gal) and active mammalian/mechanistic target of rapamycin (mTOR) in cell cycle arrest) as well as the activity of the two main pathways leading to cell senescence were examined in glucocorticoid-treated primary human tenocytes. Evid...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- Annals of the rheumatic diseases Journal website
- Volume:
- 73
- Issue:
- 7
- Pages:
- 1405-1413
- Publication date:
- 2014-01-01
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
- URN:
-
uuid:22a35877-66c3-4807-9a3d-a653e5e8696b
- Source identifiers:
-
401925
- Local pid:
- pubs:401925
- Language:
- English
- Keywords:
- Copyright holder:
- Poulsen et al.
- Copyright date:
- 2014
- Notes:
- This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Journal article
Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record